Nan Fung Life Sciences Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
14
- Investments
-
16
- Portfolio
-
13
- Exits
-
3
Nan Fung Life Sciences General Information
Company Description
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. The company does direct investments via Pivotal bioVenture Partners funds and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages. The firm has presence in both US and Greater China. It was founded in 2017 and is based in Hong Kong.
Business Details
Website
www.nanfunglifesciences.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 23rd Floor, Nan Fung Tower
- 88 Connaught Road C, Central
- Hong Kong
- Hong Kong
Nan Fung Life Sciences Investments (16)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Arkuda Therapeutics | 25-Jan-2022 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Ablaze Pharmaceuticals | 29-Nov-2021 | Drug Discovery | Startup | |||
| HotSpot Therapeutics | 16-Nov-2021 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Fountain Therapeutics | 15-Nov-2021 | Drug Discovery | Generating Revenue | |||
| Addition Therapeutics | 24-Sep-2021 | Biotechnology | Startup | |||
| Obsidian Therapeutics | 09-Sep-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Encodia | 24-Jan-2021 | Biotechnology | Generating Revenue | |||
| Selonterra | 01-Dec-2020 | Drug Discovery | Pre-Clinical Trials | |||
| Avalyn Pharma | 24-Apr-2020 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Akouos | 03-Mar-2020 | Early Stage VC | Drug Discovery | Generating Revenue |
Nan Fung Life Sciences Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Anthos Therapeutics | 03-Apr-2025 | Merger/Acquisition | |
| Navitor Pharmaceuticals | 25-Oct-2024 | ||
| Akouos | 01-Dec-2022 |
Nan Fung Life Sciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Nan Fung Life Sciences Co-Investors (47)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Atlas Venture | 3 |
|
|
||
| Pivotal bioVenture Partners |
|
|
|||
| Alexandria Venture Investments |
|
|
|||
| Revelation Partners |
|
|
|||
| Tekla Capital Management |
|
|
Nan Fung Life Sciences FAQs
-
What is Nan Fung Life Sciences?
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences.
-
When was Nan Fung Life Sciences founded?
Nan Fung Life Sciences was founded in 2017.
-
Where is Nan Fung Life Sciences headquartered?
Nan Fung Life Sciences is headquartered in Hong Kong, Hong Kong.
-
How many investments has Nan Fung Life Sciences made?
Nan Fung Life Sciences has made 16 investments.
-
What has Nan Fung Life Sciences invested in?
Nan Fung Life Sciences has made numerous investments in companies like Arkuda Therapeutics, Ablaze Pharmaceuticals, and HotSpot Therapeutics within the Drug Discovery industry.
-
What has Nan Fung Life Sciences invested in recently?
Nan Fung Life Sciences's latest investment was on 25-Jan-2022 in Arkuda Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
